Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001215028 | SCV001386747 | uncertain significance | Immunodeficiency 25 | 2022-08-09 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 63 of the CD247 protein (p.Ala63Pro). This variant is present in population databases (rs55893506, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CD247-related conditions. ClinVar contains an entry for this variant (Variation ID: 944598). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004033952 | SCV004922906 | uncertain significance | not specified | 2023-12-11 | criteria provided, single submitter | clinical testing | The c.187G>C (p.A63P) alteration is located in exon 3 (coding exon 3) of the CD247 gene. This alteration results from a G to C substitution at nucleotide position 187, causing the alanine (A) at amino acid position 63 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |